Endophthalmitis after intravitreal injections

Research output: Contribution to journalReview articlepeer-review

35 Scopus citations


Endophthalmitis following intravitreal injection is an infrequent but serious clinical problem. Infectious endophthalmitis must be differentiated from noninfectious inflammation. Depending on the series, the risk of endophthalmitis is very low. The use of a standardized injection protocol can reduce the risk of infection.

Original languageEnglish (US)
Pages (from-to)2119-2126
Number of pages8
JournalExpert Opinion on Pharmacotherapy
Issue number13
StatePublished - Sep 2009


  • Bevacizumab
  • Endophthalmitis
  • Intravitreal
  • Pegaptanib
  • Ranibizumab
  • Triamcinolone
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology


Dive into the research topics of 'Endophthalmitis after intravitreal injections'. Together they form a unique fingerprint.

Cite this